The Drug Enforcement Administration has contacted 25 “designated participants” to testify at a Dec. 2 hearing about marijuana ...

the US Drug Enforcement Administration (DEA) announced plans to hold an administrative hearing on its proposal to move “marijuana” from Schedule I of the Controlled Substances Act — the most ...

Jury deliberations in Baltimore’s opioid case against two drug distribution companies will stretch into next week.

Cannabis stocks will be in focus as DEA hearing on rescheduling marijuana is being delayed until 2025. Read more here.

And this spring, the Justice Department—including the Drug Enforcement Administration—acquiesced, marking the first loosening ...

An overview of federal and state laws and legal issues impacting physicians, non-physician practitioners (NPPs), and health ...

The settlement resolves the allegations Covetrus violated the Controlled Substances Act and other related regulations.

All recreational drug use ballot initiatives failed in the 2024 elections. Only one medical marijuana measure passed in ...

Village Farms International will represent the cannabis industry in the DEA hearing on marijuana rescheduling, the only ...

The Drug Enforcement Administration in 2006 warned drug distribution companies of a growing epidemic of prescription opioid ...

Despite complete state and federal legality, municipalities are increasingly prohibiting and prosecuting hemp-derived ...

Company advocates for commonsense reform in pivotal moment for U.S. cannabis industry –– One of the largest cannabis growers in the world, ...